RSS Feed Content – New on the website

04.02.2025

Summary report on authorisation – Abrysvo®

First authorisation

03.02.2025

Summary report on authorisation – Livmarli®

First authorisation

03.02.2025

Surveillance of the use of medical devices for anti-wrinkle injections (“fillers”)

The cantonal therapeutic product authorities and the Office for Health of Liechtenstein, in collaboration with Swissmedic, inspected the use of fillers in 82 clinics, medical practices, and cosmetic studios.

01.02.2025

Batch recall – Akynzeo IV 235 mg / 0.25 mg Konzentrat zur Herstellung einer Infusionslösung

Rückzug der Charge 44000228 bis auf Stufe Detailhandel

31.01.2025

Summary report on authorisation – Enhertu®

Extension of therapeutic indication (02)

31.01.2025

Summary report on authorisation – Filspari®

First authorisation

31.01.2025

Refined interpretation of the Mutual Recognition Agreement (MRA) between Canada and Switzerland

Swissmedic and Health Canada agreed to expand their approach regarding the implementation of the current MRA

31.01.2025

New Swiss Good Practice in the maintenance of medical devices

The revised Swiss Good Practice in the maintenance of medical devices is here! The central reference document for maintenance of medical devices has been updated and published in January. It is now available in German and French.

30.01.2025

Batch recall – M-retard Zentiva Retardtabletten

Rückzug der Chargen F03456, F04854 und F04160 bis auf Stufe Detailhandel

28.01.2025

Supposedly herbal products

Swissmedic is issuing an urgent warning regarding slimming products and other supposedly natural products

22.01.2025

Batch recall – Lisdexamfetamin Spirig HC 40mg Hartkapseln

Rückzug der Charge 20040824 bis auf Stufe Detailhandel

21.01.2025

Summary report on authorisation – Carvykti®

First authorisation

21.01.2025

Summary report on authorisation – Casgevy®

First authorisation

20.01.2025

Summary report on authorisation – Trodelvy®

Extension of therapeutic indication (01)

17.01.2025

Batch recall – Lipanthyl M Kapseln

Rückzug der Charge 13017J4 bis auf Stufe Detailhandel

17.01.2025

Summary report on authorisation – Enhertu®

Extension of therapeutic indication (03)

17.01.2025

Summary report on authorisation – Altuvoct®

First authorisation

17.01.2025

Summary report on authorisation – Velsipity®

First authorisation

16.01.2025

Legal mandate: surveillance of reporting and advertising for medicinal products

In the event of suspected infringements of the Medicinal Products Advertising Ordinance, Swissmedic is obliged to take measures

13.01.2025

Summary report on authorisation – Padcev®

Extension of therapeutic indication (01)

10.01.2025

Direktor/in

Job advertisement | Vorsitzende/r der Geschäftsleitung

10.01.2025

Octenisept® and incorrect use to irrigate deep wounds

Learning from adverse reaction reports – cases from pharmacovigilance

09.01.2025

Swissmedic Journal

Latest edition
Swissmedic Journal Dezember 2024

03.01.2025

Out-of-Stock – Feiba NF Pulver und Lösungsmittel zur Herstellung einer Injektionslösung

Befristete Bewilligung zum Vertrieb in österreichischer Aufmachung

01.01.2025

Amendment of the Ordinance on In Vitro Diagnostic Medical Devices (IVDs) and the Medical Devices Ordinance

The amended Ordinance on In Vitro Diagnostic Medical Devices (IvDO) enters into force on 1 January 2025

Last modification 01.12.2017

Top of page